0
0

To accelerate patient access to innovative medicines and clinical trials for life-threatening diseases by establishing a reciprocal approval mechanism with trusted international regulatory authorities.

3/18/2026, 8:06 AM

Summary of Bill HR 7953

The bill, titled "To accelerate patient access to innovative medicines and clinical trials for life-threatening diseases by establishing a reciprocal approval mechanism with trusted international regulatory authorities," was introduced in the 119th Congress as H.R. 7953 on March 17, 2026.

Current Status of Bill HR 7953

Bill HR 7953 is currently in the status of Bill Introduced since March 17, 2026. Bill HR 7953 was introduced during Congress 119 and was introduced to the House on March 17, 2026.  Bill HR 7953's most recent activity was Referred to the House Committee on Energy and Commerce. as of March 17, 2026

Bipartisan Support of Bill HR 7953

Total Number of Sponsors
1
Democrat Sponsors
0
Republican Sponsors
1
Unaffiliated Sponsors
0
Total Number of Cosponsors
1
Democrat Cosponsors
1
Republican Cosponsors
0
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 7953

Primary Policy Focus

Alternate Title(s) of Bill HR 7953

To accelerate patient access to innovative medicines and clinical trials for life-threatening diseases by establishing a reciprocal approval mechanism with trusted international regulatory authorities.
To accelerate patient access to innovative medicines and clinical trials for life-threatening diseases by establishing a reciprocal approval mechanism with trusted international regulatory authorities.

Comments

Rhett Bryan profile image

Rhett Bryan

672

5 hours ago

I don't like this bill. How will it impact me?